Skip to Content

Posts tagged with "Press Coverage"

  • Chemical News

    Thoughts on the Chemistry Nobel Prize

    I wrote up this year’s Nobel Prize awards in chemistry yesterday, and there’s no arguing that they’re significant achievements worthy of a prize at this level. For many chemists, though, I think that this year’s award will join the 2015, 2012, 2009, 2008, 2006, 2004, 2003, 1997, and 1993 ones (and there are arguably even mo… Read More
  • Clinical Trials

    Fighting It Out Over Stem Cells

    This is going to sound weird, but remember stem cells? I know that they’re still an active and important area of research and all, but I’m referring more to the period of political enthusiasm about fifteen years ago. Elected officials at the gubernatorial and national level all had positions on stem cell research, and there… Read More
  • Cancer

    A Glioblastoma Vaccine? Not Yet.

    If you get your biomedical breaking news from the British press, you will have heard all about a very promising vaccine treatment for glioblastoma. (“Remarkably promising” – BBC. “Could add years” – The Guardian. And there’s the Daily Mail (naturally), The Independent, and more). That would be good news, b… Read More
  • Cancer

    Cancer Sequencing Hype And Reality

    This piece in Science says something that needs to be said louder and more publicly. If you live in the US, you’ve surely seen various cancer treatment centers talking about their personalized therapy plans, and especially how they’ll tailor things to your DNA sequence and so on. You would get the impression that we have… Read More
  • Business and Markets

    On Lies, and Liars

    ]\Today’s topic is “lies”. We will start with the cases of Elizabeth Holmes and Ramesh (“Sunny”) Balwani, of Theranos. As the world knows, Theranos was not what it was represented to be – John Carreyrou of the Wall Street Journal and his extraordinary demolition job on them showed that beyond doubt. But remember… Read More
  • Press Coverage

    Gotta Be a Conclusion In Here Somewhere

    A couple of years ago, I wrote about how far too much of human nutrition research was unfit to draw conclusions from. This new story does nothing to make a person more confident in the field: it’s a detailed look at the lab of Brian Wansink at Cornell, where he hold an endowed chair. He’s… Read More
  • Alzheimer's Disease

    More Rough Alzheimer’s News

    Man, Alzheimer’s. That’s my reaction to yesterday’s news in the field. Merck started things off with news of their last-ditch attempt to see if their beta-secretase (BACE) inhibitor verubecestat (MK-8931) could be useful. I’ve been writing about that one for a while – here’s 2012, when they announced that the com… Read More
  • Press Coverage

    Where Does the News Hype Come From?

    From Chris Chambers on Twitter (of Cardiff Univ.) come some very important points about press coverage of scientific results. I often make references here to misleading and inaccurate headlines and stories in the popular press – as a scientist, it’s hard to take, seeing research results mangled in the only venues that most people will… Read More
  • Cancer

    A Hard Look At Liquid Biopsies

    This new paper has generated a lot of headlines (Science news writeup here). It reports work on the long-sought “liquid biopsy” idea for cancer screening, the use of circulating biomarkers to detect tumors via a blood test. The idea has obvious appeal, so much appeal that many news stories over the years have gotten well… Read More
  • Alzheimer's Disease

    Neurotrope: A Shameful PR Stunt

    There was some Alzheimer’s news the other day, but it wasn’t actually about Alzheimer’s. Not very much. It was more about hype, press releases, and a grievous lack of understanding of statistics. Via @AndyBiotech and @biotechtoreador on Twitter, I came across this release about an announcement from a small company called Neurot… Read More
123...